Improvement of global and regional left ventricular function in patients with previous myocardial infarction by a new beta 1 adrenoceptor partial agonist, ICI 118,587.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000328:Adult; D002316:Cardiotonic Agents / Q000494:pharmacology*; D006352:Heart Ventricles; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy / Q000503:physiopathology*; D010101:Oxygen Consumption; D011412:Propanolamines / Q000494:pharmacology*; D013268:Stimulation, Chemical; D017307:Xamoterol
D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D011412:Propanolamines; D017307:Xamoterol